1.Popliteal Artery Entrapment Syndrome: 13 Cases.
Jeonghoon LEE ; Taeseung LEE ; Inmok JUNG ; Jongwon HA ; Jungki CHUNG ; Jinwook JEONG ; Jaehyeong PARK ; Sang Joon KIM
Journal of the Korean Society for Vascular Surgery 2003;19(2):147-152
PURPOSE: Popliteal artery entrapment syndrome (PAES) is rare but major cause of non-atheromatous popliteal arterial insufficiency in young. Because of its rareness, it is often neglected or misdiagnosed as thrombosis or embolism. Consequently surgeons would lose the appropriate time of treatment. METHOD: We reviewed 11 cases of PAES from 1994 to 2002 regarding to clinical characteristics, image findings, management and their results. RESULT: Two of 11 patients had bilateral involvement. All patients were male and aged 12 to 45 year old (mean; 32.1). Intermittent claudication was presented as initial symptom in all. One had toe gangrene. Conventional arteriography (11 cases) was used as initial diagnostic method. CT (7 cases) and MR (4 cases) angiography were also used to make diagnosis. Type II PAES were most common in 7 limbs. 11 limbs of 10 patients underwent operation. One was managed conservatively because of advanced liver cirrhosis. Resection of medial head of gastrocnemius and popliteal arterial bypass were performed in 7 limbs. One myectomy with femoroposterotibial bypass, one femoropopliteal bypass without myectomy, and myectomy with patch angioplasty were performed. Postoperative complication occurred in two limbs. One had occlusion of graft, another had occluded segment of endarterectomised popliteal artery. Primary graft patency at 6 mo, 1 yr and 3 yr were 81% 81%, 81% respectively. CONCLUSION: In young patients with claudication who have localized lesion at popliteal artery, clinicians should pay attention to rule out PAES. Accurate diagnosis can be achieved by CT or MR angiography. Early surgical correction is recommended to minimize surgical procedure and reduce complication of the disease.
Angiography
;
Angioplasty
;
Diagnosis
;
Embolism
;
Extremities
;
Gangrene
;
Head
;
Humans
;
Intermittent Claudication
;
Liver Cirrhosis
;
Male
;
Middle Aged
;
Popliteal Artery*
;
Postoperative Complications
;
Thrombosis
;
Toes
;
Transplants
2.Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database
Jaehyeong CHO ; Jaeyu PARK ; Hyesu JO ; Yesol YIM ; Ho Geol WOO ; Jiyeon OH ; Dong Keon YON
Journal of Stroke 2024;26(3):463-467
3.Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database
Jaehyeong CHO ; Jaeyu PARK ; Hyesu JO ; Yesol YIM ; Ho Geol WOO ; Jiyeon OH ; Dong Keon YON
Journal of Stroke 2024;26(3):463-467
4.Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database
Jaehyeong CHO ; Jaeyu PARK ; Hyesu JO ; Yesol YIM ; Ho Geol WOO ; Jiyeon OH ; Dong Keon YON
Journal of Stroke 2024;26(3):463-467
5.Global Estimates of Reported Vaccine-Associated Ischemic Stroke for 1969–2023: A Comprehensive Analysis of the World Health Organization Global Pharmacovigilance Database
Jaehyeong CHO ; Jaeyu PARK ; Hyesu JO ; Yesol YIM ; Ho Geol WOO ; Jiyeon OH ; Dong Keon YON
Journal of Stroke 2024;26(3):463-467
6.Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
Seng Chan YOU ; Sungjae JUNG ; Joel N SWERDEL ; Patrick B RYAN ; Martijn J SCHUEMIE ; Marc A SUCHARD ; Seongwon LEE ; Jaehyeong CHO ; George HRIPCSAK ; Rae Woong PARK ; Sungha PARK
Korean Circulation Journal 2020;50(1):52-68
BACKGROUND AND OBJECTIVES: 2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited. We aimed to compare the effectiveness of first-line anti-hypertensive treatment combining 2 out of the following classes: angiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blocker (A), calcium channel blocker (C), and thiazide-type diuretics (D).METHODS: Treatment-naïve hypertensive adults without cardiovascular disease (CVD) who initiated dual anti-hypertensive medications were identified in 5 databases from US and Korea. The patients were matched for each comparison set by large-scale propensity score matching. Primary endpoint was all-cause mortality. Myocardial infarction, heart failure, stroke, and major adverse cardiac and cerebrovascular events as a composite outcome comprised the secondary measure.RESULTS: A total of 987,983 patients met the eligibility criteria. After matching, 222,686, 32,344, and 38,513 patients were allocated to A+C vs. A+D, C+D vs. A+C, and C+D vs. A+D comparison, respectively. There was no significant difference in the mortality during total of 1,806,077 person-years: A+C vs. A+D (hazard ratio [HR], 1.08; 95% confidence interval [CI], 0.97−1.20; p=0.127), C+D vs. A+C (HR, 0.93; 95% CI, 0.87−1.01; p=0.067), and C+D vs. A+D (HR, 1.18; 95% CI, 0.95−1.47; p=0.104). A+C was associated with a slightly higher risk of heart failure (HR, 1.09; 95% CI, 1.01−1.18; p=0.040) and stroke (HR, 1.08; 95% CI, 1.01−1.17; p=0.040) than A+D.CONCLUSIONS: There was no significant difference in mortality among A+C, A+D, and C+D combination treatment in patients without previous CVD. This finding was consistent across multi-national heterogeneous cohorts in real-world practice.
Adult
;
Angiotensin Receptor Antagonists
;
Antihypertensive Agents
;
Calcium Channel Blockers
;
Calcium Channels
;
Cardiovascular Diseases
;
Cohort Studies
;
Diuretics
;
Heart Failure
;
Humans
;
Hypertension
;
Korea
;
Mortality
;
Myocardial Infarction
;
Propensity Score
;
Stroke
7.Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary
Yeonchan SEONG ; Seng Chan YOU ; Anna OSTROPOLETS ; Yeunsook RHO ; Jimyung PARK ; Jaehyeong CHO ; Dmitry DYMSHYTS ; Christian G. REICH ; Yunjung HEO ; Rae Woong PARK
Healthcare Informatics Research 2021;27(1):29-38
Objectives:
We incorporated the Korean Electronic Data Interchange (EDI) vocabulary into Observational Medical Outcomes Partnership (OMOP) vocabulary using a semi-automated process. The goal of this study was to improve the Korean EDI as a standard medical ontology in Korea.
Methods:
We incorporated the EDI vocabulary into OMOP vocabulary through four main steps. First, we improved the current classification of EDI domains and separated medical services into procedures and measurements. Second, each EDI concept was assigned a unique identifier and validity dates. Third, we built a vertical hierarchy between EDI concepts, fully describing child concepts through relationships and attributes and linking them to parent terms. Finally, we added an English definition for each EDI concept. We translated the Korean definitions of EDI concepts using Google.Cloud.Translation.V3, using a client library and manual translation. We evaluated the EDI using 11 auditing criteria for controlled vocabularies.
Results:
We incorporated 313,431 concepts from the EDI to the OMOP Standardized Vocabularies. For 10 of the 11 auditing criteria, EDI showed a better quality index within the OMOP vocabulary than in the original EDI vocabulary.
Conclusions
The incorporation of the EDI vocabulary into the OMOP Standardized Vocabularies allows better standardization to facilitate network research. Our research provides a promising model for mapping Korean medical information into a global standard terminology system, although a comprehensive mapping of official vocabulary remains to be done in the future.
8.Comparison of First-Line Dual Combination Treatments in Hypertension: Real-World Evidence from Multinational Heterogeneous Cohorts
Seng Chan YOU ; Sungjae JUNG ; Joel N SWERDEL ; Patrick B RYAN ; Martijn J SCHUEMIE ; Marc A SUCHARD ; Seongwon LEE ; Jaehyeong CHO ; George HRIPCSAK ; Rae Woong PARK ; Sungha PARK
Korean Circulation Journal 2020;50(1):52-68
BACKGROUND AND OBJECTIVES:
2018 ESC/ESH Hypertension guideline recommends 2-drug combination as initial anti-hypertensive therapy. However, real-world evidence for effectiveness of recommended regimens remains limited. We aimed to compare the effectiveness of first-line anti-hypertensive treatment combining 2 out of the following classes: angiotensin-converting enzyme (ACE) inhibitors/angiotensin-receptor blocker (A), calcium channel blocker (C), and thiazide-type diuretics (D).
METHODS:
Treatment-naïve hypertensive adults without cardiovascular disease (CVD) who initiated dual anti-hypertensive medications were identified in 5 databases from US and Korea. The patients were matched for each comparison set by large-scale propensity score matching. Primary endpoint was all-cause mortality. Myocardial infarction, heart failure, stroke, and major adverse cardiac and cerebrovascular events as a composite outcome comprised the secondary measure.
RESULTS:
A total of 987,983 patients met the eligibility criteria. After matching, 222,686, 32,344, and 38,513 patients were allocated to A+C vs. A+D, C+D vs. A+C, and C+D vs. A+D comparison, respectively. There was no significant difference in the mortality during total of 1,806,077 person-years: A+C vs. A+D (hazard ratio [HR], 1.08; 95% confidence interval [CI], 0.97−1.20; p=0.127), C+D vs. A+C (HR, 0.93; 95% CI, 0.87−1.01; p=0.067), and C+D vs. A+D (HR, 1.18; 95% CI, 0.95−1.47; p=0.104). A+C was associated with a slightly higher risk of heart failure (HR, 1.09; 95% CI, 1.01−1.18; p=0.040) and stroke (HR, 1.08; 95% CI, 1.01−1.17; p=0.040) than A+D.
CONCLUSIONS
There was no significant difference in mortality among A+C, A+D, and C+D combination treatment in patients without previous CVD. This finding was consistent across multi-national heterogeneous cohorts in real-world practice.